Niagen Bioscience Inc (NAGE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Niagen Bioscience Inc, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 28.97x | 53.05x | -20.43x | -7.00x | -9.26x | -14.71x |
| P/B Ratio | 6.58x | 9.84x | 3.54x | 4.04x | 7.92x | 17.85x |
| P/S Ratio | 3.89x | 4.55x | 1.21x | 1.61x | 3.73x | 4.95x |
| Profitability | ||||||
| Gross Margin | 64.3% | 61.8% | 60.8% | 59.4% | 61.5% | 59.5% |
| Operating Margin | 11.0% | 7.8% | -6.7% | -25.9% | -40.1% | -33.5% |
| Net Margin | 13.4% | 8.6% | -5.9% | -23.0% | -40.2% | -33.6% |
| EBITDA Margin | 12.2% | 9.2% | -4.7% | -23.2% | -37.7% | -31.0% |
| Liquidity | ||||||
| Current Ratio | 4.86x | 3.57x | 2.40x | 2.61x | 2.78x | 1.96x |
| Quick Ratio | 3.83x | 3.06x | 1.70x | 1.78x | 2.00x | 1.25x |
| Leverage | ||||||
| Debt/Equity | 0.04x | 0.06x | 0.12x | 0.15x | 0.15x | 0.10x |
YoY = year-over-year change. Source: FMP..